These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 11551633)
1. Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy. Matovu E; Geiser F; Schneider V; Mäser P; Enyaru JC; Kaminsky R; Gallati S; Seebeck T Mol Biochem Parasitol; 2001 Sep; 117(1):73-81. PubMed ID: 11551633 [TBL] [Abstract][Full Text] [Related]
2. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate. Maina N; Maina KJ; Mäser P; Brun R Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860 [TBL] [Abstract][Full Text] [Related]
3. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535 [TBL] [Abstract][Full Text] [Related]
4. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo. Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572 [TBL] [Abstract][Full Text] [Related]
5. Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol. Graf FE; Ludin P; Wenzler T; Kaiser M; Brun R; Pyana PP; Büscher P; de Koning HP; Horn D; Mäser P PLoS Negl Trop Dis; 2013; 7(10):e2475. PubMed ID: 24130910 [TBL] [Abstract][Full Text] [Related]
6. Detection of mutant P2 adenosine transporter (TbAT1) gene in Trypanosoma brucei gambiense isolates from northwest Uganda using allele-specific polymerase chain reaction. Nerima B; Matovu E; Lubega GW; Enyaru JC Trop Med Int Health; 2007 Nov; 12(11):1361-8. PubMed ID: 18045263 [TBL] [Abstract][Full Text] [Related]
7. The phenomenon of treatment failures in Human African Trypanosomiasis. Brun R; Schumacher R; Schmid C; Kunz C; Burri C Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845 [TBL] [Abstract][Full Text] [Related]
8. Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal. Kazibwe AJ; Nerima B; de Koning HP; Mäser P; Barrett MP; Matovu E PLoS Negl Trop Dis; 2009 Sep; 3(9):e523. PubMed ID: 19787038 [TBL] [Abstract][Full Text] [Related]
9. Rapid identification of isometamidium-resistant stocks of Trypanosoma b. brucei by PCR-RFLP. Afework Y; Mäser P; Etschmann B; von Samson-Himmelstjerna G; Zessin KH; Clausen PH Parasitol Res; 2006 Aug; 99(3):253-61. PubMed ID: 16541260 [TBL] [Abstract][Full Text] [Related]
10. Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein. Munday JC; Tagoe DN; Eze AA; Krezdorn JA; Rojas López KE; Alkhaldi AA; McDonald F; Still J; Alzahrani KJ; Settimo L; De Koning HP Mol Microbiol; 2015 May; 96(4):887-900. PubMed ID: 25708978 [TBL] [Abstract][Full Text] [Related]
11. A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Mäser P; Sütterlin C; Kralli A; Kaminsky R Science; 1999 Jul; 285(5425):242-4. PubMed ID: 10398598 [TBL] [Abstract][Full Text] [Related]
12. Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes. Stewart ML; Burchmore RJ; Clucas C; Hertz-Fowler C; Brooks K; Tait A; Macleod A; Turner CM; De Koning HP; Wong PE; Barrett MP Eukaryot Cell; 2010 Feb; 9(2):336-43. PubMed ID: 19966032 [TBL] [Abstract][Full Text] [Related]
13. Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited. Geiser F; Lüscher A; de Koning HP; Seebeck T; Mäser P Mol Pharmacol; 2005 Sep; 68(3):589-95. PubMed ID: 15933219 [TBL] [Abstract][Full Text] [Related]
14. Drug transport and drug resistance in African trypanosomes. Mäser P; Lüscher A; Kaminsky R Drug Resist Updat; 2003 Oct; 6(5):281-90. PubMed ID: 14643298 [TBL] [Abstract][Full Text] [Related]
15. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility. Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658 [TBL] [Abstract][Full Text] [Related]
16. Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense. Graf FE; Ludin P; Arquint C; Schmidt RS; Schaub N; Kunz Renggli C; Munday JC; Krezdorn J; Baker N; Horn D; Balmer O; Caccone A; de Koning HP; Mäser P Cell Mol Life Sci; 2016 Sep; 73(17):3387-400. PubMed ID: 26973180 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482 [TBL] [Abstract][Full Text] [Related]
18. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Baker N; de Koning HP; Mäser P; Horn D Trends Parasitol; 2013 Mar; 29(3):110-8. PubMed ID: 23375541 [TBL] [Abstract][Full Text] [Related]
19. The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes. de Koning HP; Anderson LF; Stewart M; Burchmore RJ; Wallace LJ; Barrett MP Antimicrob Agents Chemother; 2004 May; 48(5):1515-9. PubMed ID: 15105099 [TBL] [Abstract][Full Text] [Related]